Matthias Herrmann

Person

Hofheim, DE

People

Patents Grantslast 30 patents

Information Patent Grant
Triazolopyridazines as PAR1 inhibitors, production thereof, and use...
- Patent number 9,079,906
- Issue date Jul 14, 2015
- Sanofi
- Uwe Heinelt
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Tricyclic pyridyl-vinyl pyrroles as PAR1 inhibitors
- Patent number 8,871,798
- Issue date Oct 28, 2014
- Sanofi
- Karl Schoenafinger
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Triazolium salts as PAR1 inhibitors, production thereof, and use as...
- Patent number 8,853,206
- Issue date Oct 7, 2014
- Sanofi
- Uwe Heinelt
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyridylvinylpyrazoloquinolines as PAR1 inhibitors
- Patent number 8,791,133
- Issue date Jul 29, 2014
- Sanofi
- Karl Schoenafinager
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Imidazopyridazines as PAR1 inhibitors, production thereof, and use...
- Patent number 8,598,177
- Issue date Dec 3, 2013
- Sanofi
- Uwe Heinelt
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
SF5 derivatives as PAR1 inhibitors, production thereof, and use as...
- Patent number 8,466,169
- Issue date Jun 18, 2013
- Sanofi
- Uwe Heinelt
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
EGLN2 variants and use thereof in preventing or treating thromboemb...
- Patent number 8,329,167
- Issue date Dec 11, 2012
- Sanofi
- Detlef Kozian
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
EGLN2 variants and use thereof in preventing or treating thromboemb...
- Patent number 8,211,427
- Issue date Jul 3, 2012
- sanofi-aventis
- Detlef Kozian
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Triazolium salts as PAR1 inhibitors, production thereof, and use as...
- Patent number 8,198,272
- Issue date Jun 12, 2012
- sanofi-aventis
- Uwe Heinelt
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
EGLN2 variants and use thereof in preventing or treating thromboemb...
- Patent number 8,114,398
- Issue date Feb 14, 2012
- sanofi-aventis
- Detlef Kozian
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Use of a GIP promoter polymorphism
- Patent number 8,084,198
- Issue date Dec 27, 2011
- sanofi-aventis
- Detlef Kozian
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Triazolopyridazines as PAR1 inhibitors, production thereof, and use...
- Patent number 8,076,336
- Issue date Dec 13, 2011
- sanofi-aventis
- Uwe Heinelt
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method for the diagnosis and treatment of cardiovascular diseases
- Patent number 8,071,297
- Issue date Dec 6, 2011
- sanofi-aventis
- Detlef Kozian
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Method of diagnosis of a predisposition to develop thrombotic disea...
- Patent number 7,785,781
- Issue date Aug 31, 2010
- Sanofi-Aventis Deutschland GmbH
- Detlef Kozian
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Patents Applicationslast 30 patents

Information Patent Application
TRIAZOLIUM SALTS AS PAR1 INHIBITORS, PRODUCTION THEREOF, AND USE AS...
- Publication number 20120208805
- Publication date Aug 16, 2012
- SANOFI
- Uwe HEINELT
- C07 - ORGANIC CHEMISTRY
Information Patent Application
EGLN2 VARIANTS AND USE THEREOF IN PREVENTING OR TREATING THROMBOEMB...
- Publication number 20120096571
- Publication date Apr 19, 2012
- SANOFI
- Detlef KOZIAN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHOD FOR THE DIAGNOSIS AND TREATMENT OF CARDIOVASCULAR DISEASES
- Publication number 20120065078
- Publication date Mar 15, 2012
- SANOFI
- Detlef KOZIAN
- G01 - MEASURING TESTING
Information Patent Application
TRIAZOLOPYRIDAZINES AS PAR1 INHIBITORS, PRODUCTION THEREOF, AND USE...
- Publication number 20120010203
- Publication date Jan 12, 2012
- Sanofi-Aventis
- Uwe HEINELT
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF THE MST PROTEIN FOR THE TREATMENT OF A THROMBOEMBOLIC DISORDER
- Publication number 20110257021
- Publication date Oct 20, 2011
- Sanofi-Aventis
- Paola CONCARI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
EGLN2 VARIANTS AND USE THEREOF IN PREVENTING OR TREATING THROMBOEMB...
- Publication number 20110123515
- Publication date May 26, 2011
- Sanofi-Aventis
- Detlef KOZIAN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
IMIDAZOPYRIDAZINES AS PAR1 INHIBITORS, PRODUCTION THEREOF, AND USE...
- Publication number 20110034456
- Publication date Feb 10, 2011
- Sanofi-Aventis
- Uwe HEINELT
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TRIAZOLIUM SALTS AS PAR1 INHIBITORS, PRODUCTION THEREOF, AND USE AS...
- Publication number 20110034452
- Publication date Feb 10, 2011
- Sanofi-Aventis
- Uwe HEINELT
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SF5 DERIVATIVES AS PAR1 INHIBITORS, PRODUCTION THEREOF, AND USE AS...
- Publication number 20110034461
- Publication date Feb 10, 2011
- Sanofi-Aventis
- Uwe HEINELT
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TRIAZOLOPYRIDAZINES AS PAR1 INHIBITORS, PRODUCTION THEREOF, AND USE...
- Publication number 20110034451
- Publication date Feb 10, 2011
- Sanofi-Aventis
- Uwe HEINELT
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF CLEC1B FOR THE DETERMINATION OF CARDIOVASCULAR AND THROMBOTI...
- Publication number 20100311053
- Publication date Dec 9, 2010
- Sanofi-Aventis
- Detlef Kozian
- G01 - MEASURING TESTING
Information Patent Application
METHOD OF DIAGNOSIS OF A PREDISPOSITION TO DEVELOP THROMBOTIC DISEA...
- Publication number 20100221738
- Publication date Sep 2, 2010
- Sanofi-Aventis Deutschland GmbH
- Detlef KOZIAN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
USE OF ADAMTS4 GENE AND PROTEIN POLYMORPHISMS
- Publication number 20100062431
- Publication date Mar 11, 2010
- Sanofi-Aventis
- Detlef Kozian
- G01 - MEASURING TESTING
Information Patent Application
METHOD FOR THE DIAGNOSIS AND TREATMENT OF CARDIOVASCULAR DISEASES
- Publication number 20090239218
- Publication date Sep 24, 2009
- Sanofi-Aventis
- Detlef Kozian
- G01 - MEASURING TESTING
Information Patent Application
EGLN2 VARIANTS AND USE THEREOF IN PREVENTING OR TREATING THROMBOEMB...
- Publication number 20090220479
- Publication date Sep 3, 2009
- Sanofi-Aventis
- Detlef Kozian
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHOD FOR DIAGNOSING THROMBOEMBOLIC DISORDERS AND CORONARY HEART D...
- Publication number 20090197774
- Publication date Aug 6, 2009
- Sanofi-Aventis
- Detlef Kozian
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
USE OF THE MST PROTEIN FOR THE TREATMENT OF A THROMBOEMBOLIC DISORDER
- Publication number 20090149375
- Publication date Jun 11, 2009
- Sanofi-Aventis
- Paola Concari
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Use of a Gip Promoter Polymorphism
- Publication number 20080312098
- Publication date Dec 18, 2008
- Sanofi-Aventis
- Detlef Kozian
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Method of Diagnosis of a Predisposition to Develop Thrombotic Disea...
- Publication number 20080038722
- Publication date Feb 14, 2008
- Detlef Kozian
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Use of LIMK-1, its analogues and ligands for the production of a me...
- Publication number 20050175601
- Publication date Aug 11, 2005
- Aventis Pharma Deutschland GmBH
- Alexander Rueck
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Matthias Herrmann

Person

Patents Grantslast 30 patents

Triazolopyridazines as PAR1 inhibitors, production thereof, and use...

Tricyclic pyridyl-vinyl pyrroles as PAR1 inhibitors

Triazolium salts as PAR1 inhibitors, production thereof, and use as...

Pyridylvinylpyrazoloquinolines as PAR1 inhibitors

Imidazopyridazines as PAR1 inhibitors, production thereof, and use...

SF5 derivatives as PAR1 inhibitors, production thereof, and use as...

EGLN2 variants and use thereof in preventing or treating thromboemb...

EGLN2 variants and use thereof in preventing or treating thromboemb...

Triazolium salts as PAR1 inhibitors, production thereof, and use as...

EGLN2 variants and use thereof in preventing or treating thromboemb...

Use of a GIP promoter polymorphism

Triazolopyridazines as PAR1 inhibitors, production thereof, and use...

Method for the diagnosis and treatment of cardiovascular diseases

Method of diagnosis of a predisposition to develop thrombotic disea...

Patents Applicationslast 30 patents

TRIAZOLIUM SALTS AS PAR1 INHIBITORS, PRODUCTION THEREOF, AND USE AS...

EGLN2 VARIANTS AND USE THEREOF IN PREVENTING OR TREATING THROMBOEMB...

METHOD FOR THE DIAGNOSIS AND TREATMENT OF CARDIOVASCULAR DISEASES

TRIAZOLOPYRIDAZINES AS PAR1 INHIBITORS, PRODUCTION THEREOF, AND USE...

USE OF THE MST PROTEIN FOR THE TREATMENT OF A THROMBOEMBOLIC DISORDER

EGLN2 VARIANTS AND USE THEREOF IN PREVENTING OR TREATING THROMBOEMB...

IMIDAZOPYRIDAZINES AS PAR1 INHIBITORS, PRODUCTION THEREOF, AND USE...

TRIAZOLIUM SALTS AS PAR1 INHIBITORS, PRODUCTION THEREOF, AND USE AS...

SF5 DERIVATIVES AS PAR1 INHIBITORS, PRODUCTION THEREOF, AND USE AS...

TRIAZOLOPYRIDAZINES AS PAR1 INHIBITORS, PRODUCTION THEREOF, AND USE...

USE OF CLEC1B FOR THE DETERMINATION OF CARDIOVASCULAR AND THROMBOTI...

METHOD OF DIAGNOSIS OF A PREDISPOSITION TO DEVELOP THROMBOTIC DISEA...

USE OF ADAMTS4 GENE AND PROTEIN POLYMORPHISMS

METHOD FOR THE DIAGNOSIS AND TREATMENT OF CARDIOVASCULAR DISEASES

EGLN2 VARIANTS AND USE THEREOF IN PREVENTING OR TREATING THROMBOEMB...

METHOD FOR DIAGNOSING THROMBOEMBOLIC DISORDERS AND CORONARY HEART D...

USE OF THE MST PROTEIN FOR THE TREATMENT OF A THROMBOEMBOLIC DISORDER

Use of a Gip Promoter Polymorphism

Method of Diagnosis of a Predisposition to Develop Thrombotic Disea...

Use of LIMK-1, its analogues and ligands for the production of a me...